1460027600-05d2956c-5fec-4b14-9893-e2272fe69dcd

The present invention relates to a method for treating allergic diseases such as asthma, comprising administering a tyrosine kinase inhibitor to a human in need of such treatment, more particularly a non-toxic, selective and potent c-kit inhibitor. These identifiers enable a client to determine whether a message is specifically targeted to that client or, as an alternative, whether the client is a member of a group of targeted clients. Individuals with high IGF status, as compared with normal reference range values, are at increased risk for developing prostate cancer. The left and right counts are used to determine the path to take when descending the b-tree in search of a specific position.